• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Illinois AG sues Baxter for polluting lake

December 21, 2017 By Sarah Faulkner

BaxterIllinois attorney general Lisa Madigan hit Baxter Healthcare (NYSE:BAX) with a lawsuit yesterday, alleging that the company’s R&D facility dumped contaminated wastewater into a tributary that feeds into Long Lake, polluting the waters beyond allowable limits.

Madigan filed the complaint in Lake County Circuit Court and urged the court to force Baxter to stop over-polluting the tributary, as well as pay a penalty for violating its National Pollutant Discharge Elimination System permit.

“This lawsuit requires Baxter to take immediate steps to prevent further polluting the lake and to pay penalties for its violations,” the attorney general said in prepared remarks.

Concerned about Baxter’s onsite wastewater treatment system, community groups have been in contact with Madigan’s office. According to reports that Baxter submitted to the state’s Environmental Protection Agency, the company violated its NPDES permit multiple times between January and May last year by releasing water that contained more than the allowable amount of total suspended solids and contaminants.

These contaminants, according to the attorney general’s office, deplete oxygen levels in water and lead to the rapid growth of plants like algae, which hurt the ecosystem.

A spokesperson for Baxter told the Daily Herald that the company “strives to be a leader in environmental compliance both globally and in the communities in which we operate.”

“Baxter is aware of the complaint filed by the Illinois attorney general and has implemented corrective and preventive actions to avoid recurrence of the issues raised in its complaint,”  spokesman John O’Malley added. “We will address the complaint through the proper channels and will not speculate or discuss specific details at this time.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Featured, Legal News, Wall Street Beat Tagged With: Baxter International

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS